Semaglutide's role extends beyond diabetes, aiding weight loss and offering cardiovascular protection, with ongoing research ...
Age differences are seen in the efficacy of treatments for type 2 diabetes, according to a study published online Feb ...
Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...
Peptide Therapeutics MarketThe global peptide therapeutics market is set for remarkable expansion, with its valuation ...
7d
Everyday Health on MSNThe Best Medication for Diabetes May Depend on AgeA new study finds SGLT2 inhibitors like Jardiance and GLP-1 drugs like Ozempic provide different benefits depending on the ...
11d
News Medical on MSNGut-derived sugars: A potential game-changer for weight management and diabetesGut bacteria-produced exopolysaccharides (EPS) help regulate metabolism by modulating gut microbiota, promoting SCFA ...
The absolute risk for thyroid cancer is low among patients receiving glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy, but risk is elevated in the first year of treatment, according to a ...
1d
Health on MSNCollagen vs. Whey: Which Protein Is Best for Muscles and Skin?The main difference between collagen and whey protein is their amino acid profile and health benefits. Collagen's amino acids ...
GLP-1 is a hormone made naturally in the gut. It plays a big role in managing blood sugar and appetite while releasing ...
Cour Pharmaceuticals Development Co. Inc. has obtained IND clearance from the FDA for CNP-103, a nanoparticle in development to address the underlying autoimmunity of type 1 diabetes. A first-in-human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results